Nutritional deficiencies in inflammatory bowel disease: Therapeutic approaches

Clinical Nutrition

Volumn 32, Issue 6, 2013, Pages 904-910

  Massironi, Sara ^a   Rossi, Roberta Elisa ^a,b   Cavalcoli, Federica Alessandra ^a,b   Della Valle, Serena ^a,b   Fraquelli, Mirella ^a   Conte, Dario ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Enteral nutrition; Inflammatory bowel disease; Nutritional deficiencies; Parenteral nutrition; Protein energy malnutrition

Indexed keywords

ALBUMIN; BUTYRIC ACID; CALCIUM; COLECALCIFEROL; COLESTYRAMINE; CORTICOSTEROID; FERRITIN; IMMUNOMODULATING AGENT; IRON; MERCAPTOPURINE; METHOTREXATE; OMEGA 3 FATTY ACID; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; STEROID;

ABDOMINAL PAIN; ALBUMIN BLOOD LEVEL; ALPHA TOCOPHEROL DEFICIENCY; BODY MASS; CALCIUM DEFICIENCY; CALCIUM INTAKE; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ENTERIC FEEDING; ENTERITIS; FAT SOLUBLE VITAMIN DEFICIENCY; FERRITIN BLOOD LEVEL; FOLIC ACID DEFICIENCY; HOME CARE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOALBUMINEMIA; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; MICRONUTRIENT DEPLETION; MORBIDITY; MORTALITY; NAUSEA; NUTRIENT MANAGEMENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; NUTRITIONAL DISORDER; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT CARE; PREVALENCE; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; RETINOL DEFICIENCY; REVIEW; SELENIUM DEFICIENCY; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ZINC DEFICIENCY;

ENTERAL NUTRITION; INFLAMMATORY BOWEL DISEASE; NUTRITIONAL DEFICIENCIES; PARENTERAL NUTRITION; PROTEIN-ENERGY MALNUTRITION;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATORY BOWEL DISEASES; MICRONUTRIENTS; NUTRITION ASSESSMENT; PARENTERAL NUTRITION; PREBIOTICS; PROBIOTICS; PROTEIN-ENERGY MALNUTRITION;

EID: 84887621526     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.03.020     Document Type: Review

References (50)

1. Amre D.K., D'Souza S., Morgan K., Seidman G., Lambrette P., Grimard G., et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102:2016-2025.
2. Chapman-Kiddell C.A., Davies P.S., Gillen L., Radford-Smith G.L. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:137-151.
3. Forbes A., Goldesgeyme E., Paulon E. Nutrition in inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2011, 10.1177/0148607111413599.
4. Lucendo A.J., De Rezende L.C. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 2009, 15:2081-2088.
5. Goh J., O'Morain A. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003, 7:307-320.
6. Long M.D., Crandall W.V., Leibowitz I.H., Duffy L., del Rosario F., Kim S.C., et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011, 17:2162-2168.
7. Valentini L., Schaper L., Buning C., Hengstermann S., Koernicke T., Tillinger W., et al. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition 2008, 24:694-702.
8. Kondrup J., Rasmussen H.H., Hamberg O., Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003, 22:321-336. Ad Hoc ESPEN Working Group.
9. Detsky A.S., McLaughlin J.R., Baker J.P., Johnston N., Whittaker S., Mendelson R.A., et al. What is subjective global assessment of nutritional status?. JPEN J Parenter Enteral Nutr 1987, 11:8-13.
10. Valentini L., Schulzke J.D. Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease. Eur J Intern Med 2011, 22:13-15.
11. Han P.D., Burke A., Baldassano R.N., Rombeau J.L., Lichtenstein G.R. Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 1999, 28:423-443.
12. Cabrè E., Gassull M.A. Nutrition in inflammatory bowel disease: impact on disease and therapy. Curr Opin Gastroenterol 2001, 17:342-349.
13. Hartman C., Eliakim R., Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009, 15:2570-2578.
14. Lochs Herbert Basics in Clinical Nutrition: nutritional support in inflammatory bowel disease. e-SPEN 2010, 5:e100-e103.
15. Jowett S.L., Seal C.J., Phillips E., Gregory W., Barton J.R., Welfare M.R. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr 2004, 23:161-170.
16. von Tirpitz C., Kohn C., Steinkamp M., Geerling I., Maier V., Möller P., et al. Lactose intolerance in active Crohn's disease: clinical value of duodenal lactase analysis. JClin Gastroenterol 2002, 34:49-53.
17. Gerson C.D., Cohen N., Janowitz H.D. Small intestine absorbitive function in regional enteritis. Gastroenterology 1973, 64:907-912.
18. Hwang C., Ross V., Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis 2012, 18:1961-1981.
19. Gomollón F., Gisbert J.P. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009, 15:4659-4665.
20. Rizvi S., Schoen R.E. Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?. Am J Gastroenterol 2011, 106:1872-1879.
21. Yakut M., Ustün Y., Kabaçam G., Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010, 21:320-323.
22. Bjarnason I., Macpherson A., Mackintosh C., Buxton-Thomas M., Forgacs I., Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997, 40:228-233.
23. Lim W.C., Hanauer S.B., Li Y.C. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2:308-315.
24. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E., et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. JBiol Chem 2010, 285:2227-2231.
25. Ananthakrishnan A.N., Khalili H., Higuchi L.M., Bao Y., Korzenik J.R., Giovannucci E.L., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012, 142:482-489.
26. Schoon E.J., Müller M.C., Vermeer C., Schurgers L.J., Brummer R.J., Stockbrügger R.W. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?. Gut 2001, 48:473-477.
27. Bousvaros A., Zurakowski D., Duggan C., Law T., Rifai N., Goldberg N.E., et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. JPediatr Gastroenterol Nutr 1998, 26:129-135.
28. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
29. Barnett M., Bermingham E., McNabb W., Bassett S., Armstrong K., Rounce J., et al. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutat Res 2010, 7:71-80.
30. Schepens M.A., Vink C., Schonewille A.J., Roelofs H.M., Brummer R.J., van der Meer R., et al. Supplemental antioxidants do not ameliorate colitis development in HLA-B27 transgenic rats despite extremely low glutathione levels in colonic mucosa. Inflamm Bowel Dis 2011, 17:2065-2075.
31. Cabré E., Domènech E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol 2012, 18:3814-3822.
32. Turner D., Zlotkin S.H., Shah P.S., Griffiths A.M. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009, 1:CD006320.
33. Russo I., Luciani A., De Cicco P., Troncone E., Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 2012, 7:e32841.
34. Kovarik J.J., Tillinger W., Hofer J., Hölzl M.A., Heinzl H., Saemann M.D., et al. Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. Eur J Clin Invest 2011, 41:291-298.
35. Yamamoto T., Nakahigashi M., Umegae S., Matsumoto K. Enteral nutrition for the maintenance of remission in Crohn's disease: a systematic review. Eur J Gastroenterol Hepatol 2010, 22:1-8.
36. Società Italiana di Nutrizione Parenterale e Enterale (SINPE) Linee Guida SINPE per la nutrizione artificiale ospedaliera 2002. Rivista Italiana di Nutrizione Parenterale e Enterale 2002, S5:S5-S8.
37. Muller C., Compher D., Druyan M.E. ASPEN Clinical Guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr 2011, 35:16-24. the American Society for Parenteral and Enteral Nutrition (ASPEN).
38. Borrelli O., Cordischi L., Cirulli M., Paganelli M., Labalestra V., Uccini S., et al. Polymeric dietalone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006, 4(7):44-53.
39. Markel T.A., Lou D.C., Pfefferkorn M., Scherer L.R., West K., Rouse T., et al. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 2008, 144:540-545.
40. Bannerjee K., Camacho-Hübner C., Babinska K., Dryhurst K.M., Edwards R., Savage M.O., et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. JPediatr Gastroenterol Nutr 2004, 38:270-275.
41. Griffiths A.M., Ohlsson A., Sherman P.M., Sutherland L.R. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995, 108:1056-1067.
42. Fernández-Banares F., Cabré E., Esteve-Comas M., Gassull M.A. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 1995, 19:356-364.
43. Messori A., Trallori G., D'Albasio G., Milla M., Vannozzi G., Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 1996, 31:267-272.
44. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007, 1:CD000542.
45. Dziechciarz P., Horvath A., Shamir R., Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007, 26:795-806.
46. Heuschkel R.B., Menache C.C., Megerian J.T., Baird A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. JPediatr Gastroenterol Nutr 2000, 31:8-15.
47. Hanai H., Iida T., Takeuchi K., Arai H., Arai O., Abe J., et al. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Dig Liver Dis 2012, 44:649-654.
48. A.S.P.E.N.Board of Directors and the clinical Guidelines Task Force Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JParenter Enteral Nutr 2002, 26:73SA-74SA.
49. Messing B., Crenn P., Beau P., Boutron-Ruault M.C., Rambaud J.C., Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999, 117:1043-1050.
50. Buchman A.L. Complications of long-term total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci 2001, 45:1-18.